Access content directly

Thomas WALTER

186
Documents

Publications

Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology

Guillaume Pontarollo , Maxime Bonjour , Thomas Walter , Mathieu Pioche , Pierre-Marie Lavrut
Virchows Archiv, 2024, ⟨10.1007/s00428-023-03722-3⟩
Journal articles hal-04490334v1

Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms

Laura Gerard , Céline Patte , Laurence Chardon , Valérie Hervieu , Léa Payen
Endocrine-Related Cancer, 2024, 31 (6), ⟨10.1530/ERC-24-0052⟩
Journal articles hal-04638761v1

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study

Margaux Mekkan-Bouv Hez , Lea Derbey , Louis de Mestier , Lorenzo D , Thomas Walter
International Journal of Surgery, 2024, ⟨10.1097/js9.0000000000001382⟩
Journal articles hal-04575949v1

French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1

Pierre Goudet , Guillaume Cadiot , Anne Barlier , Eric Baudin , Françoise Borson-Chazot
Annales d'Endocrinologie = Annals of Endocrinology, 2024, 85 (1), pp.2-19. ⟨10.1016/j.ando.2023.09.003⟩
Journal articles hal-04490329v1

Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review

Benjamin Chevalier , Lucie Coppin , Pauline Romanet , Thomas Cuny , Jean-Christophe Maïza
Journal of Clinical Endocrinology and Metabolism, 2024, ⟨10.1210/clinem/dgae055⟩
Journal articles hal-04522637v1

Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network

Laure Al Mansour , Louis de Mestier , Magalie Haissaguerre , Pauline Afchain , Julien Hadoux
Journal of Nuclear Medicine, 2024, 65 (2), pp.258-263. ⟨10.2967/jnumed.123.266063⟩
Journal articles hal-04465202v1

Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors

Loïc Cheminel , Alexandru Lupu , Timothée Wallenhorst , Vincent Lepilliez , Sarah Leblanc
The American Journal of Gastroenterology, 2024, 119 (2), pp.378-381. ⟨10.14309/ajg.0000000000002516⟩
Journal articles hal-04435460v1

Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database

Marine Perrier , Charbel Mouawad , Delphine Gueguen , Benoit Thomé , Maryse Lapeyre-Mestre
Clinics and Research in Hepatology and Gastroenterology, 2023, 47 (7), pp.102177. ⟨10.1016/j.clinre.2023.102177⟩
Journal articles hal-04489768v1

High Tumor Uptake on 18 F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network

Ophélie de Rycke , Marine Perrier , Éric Ouvrard , Clément Mennetrey , Choaib Lachachi
Journal of Nuclear Medicine, 2023, 64 (11), pp.1699-1705. ⟨10.2967/jnumed.123.265584⟩
Journal articles hal-04490390v1
Image document

Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study

Aziz Zaanan , Julie Henriques , Anthony Turpin , Sylvain Manfredi , Romain Coriat
JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩
Journal articles hal-04282951v1

Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure?

Léa Robin , Alain Sauvanet , Thomas Walter , Haythem Najah , Massimo Falconi
Surgery, 2023, 173 (5), pp.1144-1152. ⟨10.1016/j.surg.2022.12.030⟩
Journal articles hal-04489743v1

European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET )

Gregory Kaltsas , Thomas Walter , Ulrich Knigge , Christos Toumpanakis , Ana Santos
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13332⟩
Journal articles hal-04489826v1
Image document

The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier
Annals of Surgical Oncology, 2023, 30 (13), pp.8528-8541. ⟨10.1245/s10434-023-14276-8⟩
Journal articles hal-04490380v1

COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study

Nicola Fazio , Lorenzo Gervaso , Thorvardur Halfdanarson , Mohamad Sonbol , Rachel Eiring
Endocrine-Related Cancer, 2023, 30 (6), ⟨10.1530/erc-22-0395⟩
Journal articles hal-04489844v1

OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel

Vincent Hautefeuille , Thomas Walter , Christine Do Cao , Romain Coriat , Sophie Dominguez
European Journal of Endocrinology, 2023, 189 (2), pp.281-289. ⟨10.1093/ejendo/lvad094⟩
Journal articles hal-04489831v1
Image document

From netrin‐1‐targeted SPECT / CT to internal radiotherapy for management of advanced solid tumors

David Kryza , Jennifer Wischhusen , Mathieu Richaud , Maëva Hervieu , Jacqueline Sidi Boumedine
EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩
Journal articles hal-04107206v1

Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion

Adrien Patenotte , Clara Yzet , Timothée Wallenhorst , Fabien Subtil , Sarah Leblanc
Endoscopy, 2023, 55 (02), pp.192-197. ⟨10.1055/a-1866-8080⟩
Journal articles hal-04179591v1

Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network

Lucie Duponchelle , Eric Baudin , Fabien Subtil , Christine Do Cao , Eric Dansin
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩
Journal articles hal-04489849v1

Carcinoid heart disease in patients with midgut neuroendocrine tumours

Clémence Delhomme , Thomas Walter , Dimitri Arangalage , Gaspard Suc , Olivia Hentic
Journal of Neuroendocrinology, 2023, 35 (4), ⟨10.1111/jne.13262⟩
Journal articles hal-04489852v1

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

Antoine Coupier , Yves Gallien , Olivier Boillot , Thomas Walter , Olivier Guillaud
Clinical Transplantation, 2023, 37 (1), ⟨10.1111/ctr.14841⟩
Journal articles hal-04183824v1

Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial

Thomas Walter , Astrid Lievre , Romain Coriat , David Malka , Farid Elhajbi
Lancet Oncology, 2023, 24 (3), pp.297-306. ⟨10.1016/s1470-2045(23)00001-3⟩
Journal articles hal-04489738v1

EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standard

Milenea Muzzolini , Thomas Walter , Sébastien Gaujoux
Gastrointestinal Endoscopy, 2023, 98 (6), pp.1039-1040. ⟨10.1016/j.gie.2023.07.023⟩
Journal articles hal-04490396v1

Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens

Tanguy Fenouil , Pierre Marie Lavrut , Maud Rabeyrin , Mustapha Adham , Kayvan Mohkam
Pathology - Research and Practice, 2023, 244, pp.154406. ⟨10.1016/j.prp.2023.154406⟩
Journal articles hal-04168612v1

ASO Visual Abstract: The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery—A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier
Annals of Surgical Oncology, 2023, 31 (2), pp.1144-1145. ⟨10.1245/s10434-023-14382-7⟩
Journal articles hal-04490348v1

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours

Marine Perrier , Jean-Yves Scoazec , Thomas Walter
Therapeutic Advances in Medical Oncology, 2023, 15, pp.175883592311710. ⟨10.1177/17588359231171041⟩
Journal articles hal-04489754v1

Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network

Lucie Duponchelle , Eric Baudin , Fabien Subtil , Christine Do Cao , Eric Dansin
Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩
Journal articles hal-04517673v1

Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network

Marine Perrier , Mathias Brugel , Laura Gerard , Bernard Goichot , Astrid Lièvre
European Journal of Endocrinology, 2023, European Journal of Endocrinology, 189 (6), pp.575-583. ⟨10.1093/ejendo/lvad157⟩
Journal articles hal-04338301v1

887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial

E. Baudin , Thomas Walter , A. Beron , D. Smith , J. Hadoux
Annals of Oncology, 2022, 33, pp.S954. ⟨10.1016/j.annonc.2022.07.1013⟩
Journal articles hal-04490313v1

Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

Nicolas Benech , Sylvie Bonvalot , Armelle Dufresne , Afshin Gangi , Cécile Le Péchoux
Digestive and Liver Disease, 2022, 54 (6), pp.737-746. ⟨10.1016/j.dld.2022.03.004⟩
Journal articles hal-03925724v1

Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma

Armelle Schoch , Andrea Lisotti , Thomas Walter , Fabien Fumex , Sarah Leblanc
Endoscopic Ultrasound, 2022, 11 (6), pp.487. ⟨10.4103/eus-d-22-00014⟩
Journal articles hal-04490222v1

Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability

Claire Boyer , David Sefrioui , Romain Cohen , Romain Chautard , Marine Perrier
Digestive and Liver Disease, 2022, ⟨10.1016/j.dld.2022.03.011⟩
Journal articles hal-03731980v1

Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study

Sébastien Gaujoux , Guillaume Martin , Eric Mirallié , Nicolas Regenet , Maëlle Le Bras
British Journal of Surgery, 2022, 109 (9), pp.872-879. ⟨10.1093/bjs/znac006⟩
Journal articles hal-03883938v1
Image document

Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort

Gaël Roth , Yohan Fayet , Sakina Benmameche-Medjahed , Françoise Ducimetière , Amandine Charreton
Cancers, 2022, 14 (21), pp.5413. ⟨10.3390/cancers14215413⟩
Journal articles hal-04490226v1

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Frederic Mercier , Guillaume Passot , Pierre‐emmanuel Bonnot , Peter Cashin , Wim Ceelen
World Journal of Surgery, 2022, 46 (6), pp.1336-1343. ⟨10.1007/s00268-022-06498-w⟩
Journal articles hal-04490255v1

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis

Roy Hajjar , Frederic Mercier , Guillaume Passot , Arnaud Pasquer , Maximiliano Gelli
EJSO - European Journal of Surgical Oncology, 2022, 48 (7), pp.1626-1630. ⟨10.1016/j.ejso.2022.03.019⟩
Journal articles hal-04490265v1

Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion

Adrien Patenotte , Clara Yzet , Timothée Wallenhorst , Fabien Subtil , Sarah Leblanc
Endoscopy, 2022, 55 (02), pp.192-197. ⟨10.1055/a-1866-8080⟩
Journal articles hal-04500038v1
Image document

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

Côme Lepage , J-M. Phelip , Astrid Lièvre , Karine Le Malicot , L Dahan
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
Journal articles hal-03810530v1

Second-Line Treatment and Prognostic Factors in Neuroendocrine Carcinoma.

Julien Hadoux , Thomas Walter , Christina Kanaan , Ségolène Hescot , Vincent Hautefeuille
Endocrine-Related Cancer, 2022, 29 (10), p.569-580. ⟨10.1530/ERC-22-0102⟩
Journal articles hal-03746086v1

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors

Paul Girot , Eric Baudin , Hélène Senellart , Nadia Bouarioua , Olivia Hentic
Neuroendocrinology, 2022, 112 (6), pp.537-546. ⟨10.1159/000518650⟩
Journal articles hal-04490284v1

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease

M. Flagiello , M. Pozzi , L. Francois , A. Al Harthy , J. Forestier
Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩
Journal articles inserm-03831063v1

Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.

Xixi Ye-Tran , Mohamed Bouattour , Audrey Perret , Anthony Turpin , Thomas Walter
Journal of Clinical Oncology, 2022, 40 (16_suppl), pp.e16194-e16194. ⟨10.1200/JCO.2022.40.16_suppl.e16194⟩
Journal articles hal-04489869v1

Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study

Marine Perrier , Stéphanie Polazzi , Annie Lemelin , Violaine Fernandez , Stéphanie Labonne
Journal of Neuroendocrinology, 2022, 34 (4), ⟨10.1111/jne.13092⟩
Journal articles hal-04151010v1
Image document

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Clément Mennetrey , Maëlle Le Bras , Aurélie Bando-Delaunay , Laure Al-Mansour , Magalie Haissaguerre
Journal of Clinical Endocrinology and Metabolism, 2022, 107 (5), pp.e2056-e2064. ⟨10.1210/clinem/dgab891⟩
Journal articles hal-03662789v1

Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence

Carole Morin , Keo-Morakort Benedetto , Agathe Deville , Laurent Milot , Aurélie Theillaumas
Endocrine Connections, 2022, 11 (6), ⟨10.1530/EC-22-0097⟩
Journal articles hal-04490245v1

18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors

Eric Ouvrard , Louis de Mestier , Caroline Boursier , Boumediene Lachachi , Nicolas Sahakian
J.Nucl.Med., 2022, 63 (12), pp.1865-1870. ⟨10.2967/jnumed.122.263984⟩
Journal articles hal-03954228v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis within the lungNENomics Project

A. Sexton-Oates , A. Di Genova , L. Mangiante , C. Voegele , S. Tabone-Eglinger
Journal of Thoracic Oncology, 2022, 17 (9), pp.S45-S46
Journal articles cea-04352533v1
Image document

FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin

Julien Hadoux , Pauline Afchain , Thomas Walter , David Tougeron , Vincent Hautefeuille
Digestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩
Journal articles hal-03333521v1

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome

Laura Gerard , David Barthelemy , Arnaud Gauthier , Valerie Hervieu , Jonathan Lopez
Endocrine Oncology, 2021, 1 (1), pp.K1-K6. ⟨10.1530/eo-21-0012⟩
Journal articles hal-04492472v1

Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1)

Eric Assenat , Laurent Mineur , Caroline Mollevi , Evelyne Lopez-Crapez , Catherine Lombard-Bohas
International Journal of Cancer, 2021, 148 (3), pp.682-691. ⟨10.1002/ijc.33225⟩
Journal articles hal-03670041v1

Value of a patient-reported-outcome measure of carcinoid syndrome symptoms

Juliette Maurel , Rosine Guimbaud , Thierry Lecomte , Astrid Lièvre , Vincent Hautefeuille
European Journal of Endocrinology, 2021, 184 (5), pp.711-722. ⟨10.1530/EJE-20-1138⟩
Journal articles hal-04179679v1
Image document

Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)

Anne-Sophie Belmont , Christophe Sajous , Amandine Bruyas , Sara Calattini , Stéphanie Cartalat
Cancers, 2021, 14 (1), pp.29. ⟨10.3390/cancers14010029⟩
Journal articles hal-04490309v1
Image document

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Melissa Frizziero , Alice Durand , Rodrigo Taboada , Elisa Zaninotto , Claudio Luchini
Cancers, 2021, 13 (16), pp.4152. ⟨10.3390/cancers13164152⟩
Journal articles hal-04492480v1
Image document

Principles of Surgical Management of Small Intestinal NET

Arnaud Pasquer , Thomas Walter , Laurent Milot , Valérie Hervieu , Gilles Poncet
Cancers, 2021, 13 (21), pp.5473. ⟨10.3390/cancers13215473⟩
Journal articles hal-04492163v1
Image document

Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Julien Hadoux , Christina Kanaan , Alice Durand , Segolene Hescot , Vincent Hautefeuille
European journal of cancer, 2021, 152, pp.100-115. ⟨10.1016/j.ejca.2021.04.030⟩
Journal articles hal-03600262v1

Efficacy of treatments for VIPoma: A GTE multicentric series

Mathias Brugel , Thomas Walter , Bernard Goichot , Denis Smith , Côme Lepage
Pancreatology, 2021, 21 (8), pp.1531-1539. ⟨10.1016/j.pan.2021.08.001⟩
Journal articles hal-04492502v1
Image document

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database

Christelle de la Fouchardière , Mustapha Adham , Anne-Marie Marion-Audibert , Antoine Duclos , Claude Darcha
Cancers, 2021, 13 (14), pp.3515. ⟨10.3390/cancers13143515⟩
Journal articles hal-04492495v1

Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature

K. Hodroj , D. Barthelemy , J.-C. Lega , G. Grenet , M.-C. Gagnieu
ESMO Open, 2021, 6 (3), pp.100125. ⟨10.1016/j.esmoop.2021.100125⟩
Journal articles hal-04492195v1
Image document

Targeting netrin‐3 in small cell lung cancer and neuroblastoma

Shan Jiang , Mathieu Richaud , Pauline Vieugué , Nicolas Rama , Jean‐guy Delcros
EMBO Molecular Medicine, 2021, 13 (4), ⟨10.15252/emmm.202012878⟩
Journal articles hal-03410529v1

Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study

Louis de Mestier , Frédérique Savagner , Hedia Brixi , Christine Do Cao , Sophie Dominguez-Tinajero
Journal of Clinical Endocrinology and Metabolism, 2021, 106 (4), pp.e1673-e1682. ⟨10.1210/clinem/dgaa924⟩
Journal articles hal-03287271v1

Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors

Ophélie de Rycke , Thomas Walter , Marine Perrier , Olivia Hentic , Catherine Lombard-Bohas
Endocrine-Related Cancer, 2021, 28 (7), pp.457-466. ⟨10.1530/erc-21-0034⟩
Journal articles hal-04492482v1

Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases

Nicolas Benech , Jean Marc O'Brien , Maximilien Barret , Jéremie Jacques , Gabriel Rahmi
United European Gastroenterology Journal, 2021, 9 (3), pp.362-369. ⟨10.1177/2050640620958903⟩
Journal articles hal-04470221v1

Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms

Servane Gay-Chevallier , Louis de Mestier , Julie Perinel , Julien Forestier , Valérie Hervieu
Neuroendocrinology, 2021, 111 (8), pp.718-727. ⟨10.1159/000508102⟩
Journal articles hal-04179693v1

Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer
Annals of translational medicine, 2021, 9 (1), pp.50-50. ⟨10.21037/atm-20-3474⟩
Journal articles hal-04492172v1
Image document

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma

Thomas Couronne , Paul Girot , Julien Hadoux , Thierry Lecomte , Alice Durand
Endocrine Connections, 2020, 9 (6), pp.498-505. ⟨10.1530/ec-20-0192⟩
Journal articles hal-04492751v1

Endoscopic characterization of rectal neuroendocrine tumors with virtual chromoendoscopy: differences between benign and malignant lesions

Florian Veyre , Thomas Lambin , Caroline Fine , Tanguy Fenouil , Florian Rostain
Endoscopy, 2020, 53 (06), pp.E215-E216. ⟨10.1055/a-1244-9526⟩
Journal articles hal-04491996v1

Unifocal versus multiple ileal neuroendocrine tumors location: an embryological origin

Maroin Kalifi , Thomas Walter , Laurent Milot , Valérie Hervieu , Ingrid Millot
Neuroendocrinology, inPress, ⟨10.1159/000511849⟩
Journal articles hal-02999432v1

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors

Marine Perrier , Olivia Hentic , Thomas Walter , Christine Do Cao , Guillaume Cadiot
Digestive and Liver Disease, 2020, 52 (12), pp.1521-1524. ⟨10.1016/j.dld.2020.09.001⟩
Journal articles hal-04492690v1

Extrapulmonary poorly differentiated NECs, including molecular and immune aspects

Mairéad Mcnamara , Jean-Yves Scoazec , Thomas Walter
Endocrine-Related Cancer, 2020, 27 (7), pp.R219-R238. ⟨10.1530/erc-19-0483⟩
Journal articles hal-04493496v1

Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors

Maximilien Minon , Clothilde Soriano , David Morland , Thomas Walter , Côme Lepage
Endocrine, 2020, 67, pp.243-251. ⟨10.1007/s12020-019-02095-5⟩
Journal articles hal-02478376v1
Image document

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier , Thomas Walter , Camille Evrard , Paul de Boissieu , Olivia Hentic
Neuroendocrinology, 2020, 110 (1-2), pp.83-91. ⟨10.1159/000500862⟩
Journal articles hal-04492743v1

Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Emmanuel Forté , Bérénice Petit , Thomas Walter , Vincent Lépilliez , Geoffroy Vanbiervliet
Endoscopy, 2020, 52 (06), pp.444-453. ⟨10.1055/a-1117-3166⟩
Journal articles hal-04179697v1

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Louis de Mestier , Come Lepage , Eric Baudin , Romain Coriat , Frédéric Courbon
Digestive and Liver Disease, 2020, 52 (5), pp.473-492. ⟨10.1016/j.dld.2020.02.011⟩
Journal articles hal-04492748v1
Image document

Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer

Thomas Walter , Neil Hawkins , Richard Pollock , Fabien Colaone , Suki Shergill
Journal of Cancer Research and Clinical Oncology, 2020, 146 (10), pp.2575-2587. ⟨10.1007/s00432-020-03315-6⟩
Journal articles hal-04492656v1
Image document

Metformin and everolimus in neuroendocrine tumours: A synergic effect?

Lucia Hue-Fontaine , Annie Lemelin , Julien Forestier , Gerald Raverot , Laurent Milot
Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.954 - 960. ⟨10.1016/j.clinre.2020.02.011⟩
Journal articles hal-03492643v1

Cost-effectiveness of Lutetium [ 177 Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France

O. Leeuwenkamp , J. Smith-Palmer , R. Ortiz , A. Werner , W. Valentine
Journal of Medical Economics, 2020, 23 (12), pp.1534-1541. ⟨10.1080/13696998.2020.1830286⟩
Journal articles hal-04492707v1

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

Mohid Khan , Thomas Walter , Amy Buchanan-Hughes , Emma Worthington , Lucie Keeber
World Journal of Gastroenterology, 2020, 26 (30), pp.4537-4556. ⟨10.3748/wjg.v26.i30.4537⟩
Journal articles hal-04492712v1

Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study

Annie Lemelin , Delphine Maucort-Boulch , Elisabeth Castel-Kremer , Julien Forestier , Valérie Hervieu
Neuroendocrinology, 2020, 110 (7-8), pp.653-661. ⟨10.1159/000503901⟩
Journal articles hal-04151916v1

Diagnostic endoscopic submucosal dissection with targeted tunnel to reach the suspect area first in order to diagnose muscular invasion and differentiate T1b from T2 cancers

Camille Meunier , Jérémie Jacques , Jérôme Rivory , Thomas Lambin , Thomas Walter
Endoscopy, 2020, 53 (08), pp.870-871. ⟨10.1055/a-1268-7057⟩
Journal articles hal-04470335v1

Endoscopic ultrasound-guided gastrostomy to avoid interposed digestive loop is effective when lack of transillumination prevents percutaneous approach

Juliette Maurel , Gaspard Bertrand , Florian Beoletto , Thierry Ponchon , Thomas Walter
Endoscopy, 2020, 52 (11), pp.E402-E403. ⟨10.1055/a-1149-1224⟩
Journal articles hal-04493508v1

ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study

Laura Gerard , Jessica Garcia , Arnaud Gauthier , Jonathan Lopez , Alice Durand
Neuroendocrinology, inPress, ⟨10.1159/000512502⟩
Journal articles hal-02999436v1
Image document

Chemotherapy in resected neuroendocrine carcinomas of the digestive

Anna Pellat , Thomas Walter , Jeremy Augustin , Vincent Hautefeuille , Olivia Hentic
Neuroendocrinology, 2020, 110 (5), pp.404-412. ⟨10.1159/000502825⟩
Journal articles hal-02996214v1
Image document

Prognostic and predictive value of nuclear imaging in endocrine oncology

Giorgio Treglia , Bernard Goichot , Luca Giovanella , Elif Hindié , Abhishek Jha
Endocrine, 2019, 67 (1), pp.9-19. ⟨10.1007/s12020-019-02131-4⟩
Journal articles hal-04492687v1
Image document

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors

Louis de Mestier , Diane Lorenzo , Caroline Fine , Jérôme Cros , Olivia Hentic
Best Practice and Research: Clinical Endocrinology and Metabolism, 2019, 33, pp.101293 -. ⟨10.1016/j.beem.2019.101293⟩
Journal articles hal-03489062v1

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter , Come Lepage , Romain Coriat , Emilie Barbier , Guillaume Cadiot
European Journal of Cancer, 2019, 123, pp.92-100. ⟨10.1016/j.ejca.2019.09.021⟩
Journal articles hal-04493861v1
Image document

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases

Alessio Imperiale , Gilles Poncet , Pietro Addeo , Elisa Ruhland , Colette Roche
Metabolites, 2019, 9 (12), pp.300. ⟨10.3390/metabo9120300⟩
Journal articles hal-02923574v1

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors : A National Study from the French Group of Endocrine Tumors (GTE)

Bérénice Rault-Petit , Christine Do Cao , Serge Guyétant , Rosine Guimbaud , Vincent Rohmer
Annals of Surgery, 2019, 270 (1), pp.165-171. ⟨10.1097/SLA.0000000000002736⟩
Journal articles hal-02547901v1
Image document

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)

Annie Lemelin , Marc Barritault , Valérie Hervieu , Léa Payen , Julien Péron
Digestive and Liver Disease, 2019, 51, pp.595 - 599. ⟨10.1016/j.dld.2019.02.001⟩
Journal articles hal-03486315v1
Image document

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres

Melissa Frizziero , Xin Wang , Bipasha Chakrabarty , Alexa Childs , Tu Luong
World Journal of Gastroenterology, 2019, 25 (39), pp.5991-6005. ⟨10.3748/wjg.v25.i39.5991⟩
Journal articles hal-04493932v1
Image document

Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors

Patrick Robelin , Julien Hadoux , Julien Forestier , David Planchard , Valérie Hervieu
Journal of Thoracic Oncology, 2019, 14, pp.993 - 1002. ⟨10.1016/j.jtho.2019.02.002⟩
Journal articles hal-03484938v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Louis de Mestier , Thomas Walter , Hedia Brixi , Camille Evrard , Jean-Louis Legoux
Neuroendocrinology, 2019, 108 (4), pp.343-353. ⟨10.1159/000498887⟩
Journal articles hal-04493972v1

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)

Caroline Fine , Guillaume Roquin , Eric Terrebonne , Thierry Lecomte , Romain Coriat
United European Gastroenterology Journal, 2019, 7 (8), pp.1102-1112. ⟨10.1177/2050640619861883⟩
Journal articles hal-02549178v1
Image document

Nonampullary duodenal subepithelial neuroendocrine tumor removed R0 by endoscopic submucosal dissection with double clips and rubber band traction

Borathchakra Oung , Thomas Walter , Valérie Hervieu , Jérémie Jacques , Mathieu Pioche
VideoGIE, 2019, 4 (12), pp.570-573. ⟨10.1016/j.vgie.2019.08.006⟩
Journal articles hal-04493877v1
Image document

Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases

V. Kepenekian , A. Muller , P. Valette , P. Rousset , M. Chauvenet
BJS Open, 2019, 3 (3), pp.344-353. ⟨10.1002/bjs5.50140⟩
Journal articles hal-04493892v1

Narrow-band imaging detects synchronous oropharyngeal squamous carcinoma during treatment of an early esophageal squamous cell carcinoma

Alexander Katzarov , Alexandru Lupu , Jérémie Jacques , Jérôme Rivory , Florian Rostain
Endoscopy, 2018, 50 (09), pp.E264-E266. ⟨10.1055/a-0640-2464⟩
Journal articles hal-04495732v1

Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease

Jérôme Dumortier , Delphine Maucort-Boulch , Domitille Poinsot , Elsa Thimonier , Christine Chambon-Augoyard
Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (5), pp.427-435. ⟨10.1016/j.clinre.2018.04.011⟩
Journal articles hal-04151948v1
Image document

Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery

Myrtille Fouché , Yves Bouffard , Mary-Charlotte Le Goff , Johanne Prothet , François Malavieille
Endocrine Connections, 2018, 7 (12), pp.1245-1250. ⟨10.1530/ec-18-0324⟩
Journal articles hal-04494027v1

Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors

Arnaud Plante , Eric Baudin , Christine Do Cao , Olivia Hentic , Olivier Dubreuil
Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (2), pp.153-159. ⟨10.1016/j.clinre.2017.10.003⟩
Journal articles hal-04495704v1

A motivational phone call improves participation to screening colonoscopy for those with a positive FIT in a national screening programme (NCT 03276091)

Clémentine Gandilhon , Patricia Soler-Michel , Léa Vecchiato , Claude Chaunier , Isabelle Fay
Digestive and Liver Disease, 2018, 50 (12), pp.1309-1314. ⟨10.1016/j.dld.2018.08.007⟩
Journal articles hal-04493977v1

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

Anna Pellat , Chantal Dreyer , Camille Couffignal , Thomas Walter , Catherine Lombard-Bohas
Neuroendocrinology, 2018, 107 (1), pp.24-31. ⟨10.1159/000487237⟩
Journal articles hal-04495727v1
Image document

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer
Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩
Journal articles hal-04383088v1

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer
Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩
Journal articles hal-03625758v1

An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma

Elisabeth Castel-Kremer , Solene de Talhouet , Anne-Laure Charlois , Emmanuelle Graillot , Xavier Chopin-Laly
Journal of Geriatric Oncology, 2018, 9 (4), pp.373-381. ⟨10.1016/j.jgo.2018.03.007⟩
Journal articles hal-04494047v1

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Thomas Walter , David Malka , Olivia Hentic , Catherine Lombard-Bohas , Karine Le Malicot
Digestive and Liver Disease, 2018, 50 (2), pp.195-198. ⟨10.1016/j.dld.2017.11.020⟩
Journal articles hal-01699411v1

Gastric neuroendocrine tumors display deep invasive features, with amorphous pit and irregular vascular pattern, using narrow-band imaging and magnification

Adrien Choné , Thomas Walter , Jérôme Rivory , Pierre-Marie Lavrut , Julien Forestier
Endoscopy, 2018, 50 (08), pp.E199-E201. ⟨10.1055/a-0606-4792⟩
Journal articles hal-04494046v1

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells

Julien Bollard , Céline Patte , Patrick Massoma , Isabelle Goddard , Nicolas Gadot
Molecular Cancer Therapeutics, 2018, 17 (1), pp.60-72. ⟨10.1158/1535-7163.MCT-17-0325⟩
Journal articles hal-04494066v1
Image document

Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer
Cancer Management and Research, 2018, Volume 10, pp.3825-3831. ⟨10.2147/cmar.S163141⟩
Journal articles hal-04493982v1

Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines

Margaux Foulfoin , Emmanuelle Graillot , Mustapha Adham , Pascal Rousset , Julien Forestier
Endocrine-Related Cancer, 2017, 24 (2), pp.71-81. ⟨10.1530/erc-16-0464⟩
Journal articles hal-04494085v1

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)

Guillaume Roquin , Éric Baudin , Catherine Lombard-Bohas , Guillaume Cadiot , Sophie Dominguez
Neuroendocrinology, 2017, 106 (1), pp.38-46. ⟨10.1159/000457955⟩
Journal articles hal-02451453v1

Maintaining quality of life for patients with neuroendocrine tumours

Thomas Walter
Lancet Oncology, 2017, 18 (10), pp.1299-1300. ⟨10.1016/s1470-2045(17)30618-6⟩
Journal articles hal-04495910v1
Image document

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines

Patricia Freis , Julien Bollard , Justine Lebeau , Patrick Massoma , Joëlle Fauvre
Oncotarget, 2017, 8 (13), pp.20974-20987. ⟨10.18632/oncotarget.15469⟩
Journal articles hal-02379643v1

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours

Come Lepage , Laetitia Dahan , Nadia Bouarioua , Christos Toumpanakis , Jean-Louis Legoux
Digestive and Liver Disease, 2017, 49 (5), pp.568 - 571. ⟨10.1016/j.dld.2017.02.004⟩
Journal articles hal-01599909v1
Image document

Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers

Patricia Freis , Emmanuelle Graillot , Pascal Rousset , Valérie Hervieu , Laurence Chardon
Scientific Reports, 2017, 7 (1), pp.40609. ⟨10.1038/srep40609⟩
Journal articles hal-04500093v1

Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments

Thomas Walter , C Zhenzhen Wang , O Guillaud , E Cotte , A Pasquer
United European Gastroenterology Journal, 2017, 5 (5), pp.735-741. ⟨10.1177/2050640616678150⟩
Journal articles hal-04495896v1

In Reply

Romain Coriat , Benoît Terris , Thomas Walter
Oncologist, 2017, 22 (3), pp.359-360. ⟨10.1634/theoncologist.2016-0393⟩
Journal articles hal-04495937v1
Image document

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas

Angela Lamarca , Thomas Walter , Marianne Pavel , Ivan Borbath , Patricia Freis
JNCI: Journal of the National Cancer Institute, 2017, 109 (5), pp.djw277. ⟨10.1093/jnci/djw277⟩
Journal articles hal-04495933v1

Desmoid Tumors and Celecoxib with Sorafenib

Nicolas Benech , Thomas Walter , Jean-Christophe Saurin
New England Journal of Medicine, 2017, 376 (26), pp.2595-2597. ⟨10.1056/NEJMc1702562⟩
Journal articles hal-04495950v1

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

T. Walter , T Tougeron , Emmanuel Baudin , K. Le Malicot , T. Lecomte
European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩
Journal articles hal-01609152v1
Image document

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Sylvain Manfredi , Thomas Walter , Eric Baudin , Philippe Ruszniewski , Thierry Lecomte
Endocrine, 2017, 57 (3), pp.504-511. ⟨10.1007/s12020-017-1355-9⟩
Journal articles hal-01576810v1

Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study

Davide Campana , Thomas Walter , Sara Pusceddu , Fabio Gelsomino , Emmanuelle Graillot
Endocrine, 2017, 60 (3), pp.490-498. ⟨10.1007/s12020-017-1474-3⟩
Journal articles hal-04494061v1

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

Jonathan Olesinski , François Mithieux , Olivier Guillaud , Marie-Noëlle Hilleret , Catherine Lombard-Bohas
Annals of Nuclear Medicine, 2017, 31 (5), pp.379-389. ⟨10.1007/s12149-017-1165-4⟩
Journal articles hal-04173123v1

Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up

C. Nozieres , L. Chardon , B. Goichot , F. Borson-Chazot , V. Hervieu
European Journal of Endocrinology, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩
Journal articles hal-01850353v1

Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement

J. Perinel , G. Nappo , M. El Bechwaty , Thomas Walter , V. Hervieu
Langenbeck's Archives of Surgery, 2016, 401 (8), pp.1131-1142. ⟨10.1007/s00423-016-1488-y⟩
Journal articles hal-04496006v1

Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors

Thomas Walter , D. Planchard , K. Bouledrak , J.Y. Scoazec , P.J. Souquet
Lung Cancer, 2016, 96, pp.68-73. ⟨10.1016/j.lungcan.2016.03.018⟩
Journal articles hal-04495958v1

Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC , and PTEN genes

Marco Petronio , Stephane Pinson , Thomas Walter , Marie‐odile Joly , Valerie Hervieu
United European Gastroenterology Journal, 2016, 4 (2), pp.305-313. ⟨10.1177/2050640615594939⟩
Journal articles hal-04495988v1
Image document

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma

Bertrand Brieau , Céline Lepère , Thomas Walter , Thierry Lecomte , Rosine Guimbaud
Medicine, 2015, 94 (42), pp.e1864. ⟨10.1097/MD.0000000000001864⟩
Journal articles hal-01301145v1

Antitumor Effect of Everolimus in Preclinical Models of High Grade Gastroenteropancreatic Neuroendocrine Carcinomas.

Julien Bollard , Christophe Couderc , Martine Blanc , Gilles Poncet , Florian Lepinasse
Neuroendocrinology, 2013, epub ahead of print. ⟨10.1159/000347063⟩
Journal articles hal-00790198v1

Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound

A. Guibal , C. Boularan , M. Bruce , M. Vallin , F. Pilleul
European Radiology, 2013, 23 (4), pp.1138--1149. ⟨10.1007/s00330-012-2692-y⟩
Journal articles hal-01918694v1

Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation

A. Guibal , T. Lefort , L. Chardon , N. Benslama , S. Mule
European Radiology, 2013, 23 (3), pp.805--815. ⟨10.1007/s00330-012-2646-4⟩
Journal articles hal-01918695v1

Obstructing minute primary endocrine tumor of the main pancreatic duct: diagnostic relevance of endoscopic ultrasonography

R. Gincul , T. Walter , B. Napoleon , C. Lombard-Bohas , C. Partensky
Pancreas, 2012, 41 (1), pp.164--165
Journal articles hal-01918698v1

Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation

T. Lefort , F. Pilleul , S. Mule , S. L. Bridal , F. Frouin
Ultrasound in Medicine & Biology, 2012, 38 (6), pp.953--961
Journal articles hal-01918702v1

Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growth.

Christophe Couderc , Gilles Poncet , Karine Villaume , Martine Blanc , Nicolas Gadot
American Journal of Pathology, 2011, 178 (1), pp.336-44. ⟨10.1016/j.ajpath.2010.11.023⟩
Journal articles hal-00710288v1

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.

Francesco Giammarile , Claire Billotey , Catherine Lombard-Bohas , Didier Le Bars , Claire Bournaud
Nuclear Medicine Communications, 2011, 32 (2), pp.91-7. ⟨10.1097/MNM.0b013e3283412143⟩
Journal articles hal-00814028v1

Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

Thomas Walter , Jean-Yves Scoazec , Christophe Couderc , Julien Forestier , Colette Roche
Acta Oncologica, 2011, 50 (5), pp.731-2. ⟨10.3109/0284186X.2011.562919⟩
Journal articles hal-00710300v1

Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.

Thomas Walter , Juliette Hommell-Fontaine , Géraldine Gouysse , Céline Pourreyron , Mimoun Nejjari
Neuroendocrinology, 2011, 94 (3), pp.200-8. ⟨10.1159/000328134⟩
Journal articles hal-00710320v1

Primary neuroendocrine tumors of the main pancreatic duct: a rare entity.

Thomas Walter , Valérie Hervieu , Mustapha Adham , Rodica Gincul , Gilles Poncet
Virchows Archiv, 2011, 458 (5), pp.537-46. ⟨10.1007/s00428-011-1067-0⟩
Journal articles hal-00713749v1

F-18-FLT and F-18-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

F. Giammarile , C. Billotey , C. Lombard-Bohas , D. Le Bars , C. Bournaud
Nuclear Medicine Communications, 2011, 32, pp.91-97
Journal articles hal-02299115v1

Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases

G. Poncet , V. Hervieu , T. Walter , F. Lepinasse , L. Chardon
Journal of Gastrointestinal Surgery, 2011, 15 (1), pp.101--109
Journal articles hal-01918705v1

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway.

Karine Villaume , Martine Blanc , Géraldine Gouysse , Thomas R. Walter , Christophe Couderc
Neuroendocrinology, 2010, epub ahead of print. ⟨10.1159/000289569⟩
Journal articles hal-00475083v1

TIPS thrombosis related to abdominal trauma

F. Pietu , T. Walter , O. Guillaud , F. Pilleul , J. Dumortier
European Journal of Gastroenterology & Hepatology, 2010, 22 (7), pp.883--885
Journal articles hal-01918719v1

Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors

T. Walter , D. Bruneton , P. A. Cassier , V. Hervieu , F. Pilleul
Clinical Colorectal Cancer, 2010, 9 (4), pp.248--254
Journal articles hal-01918720v1

Transcatheter local thrombolysis in patients with extensive TIPS thrombosis

J. Dumortier , T. Walter , O. Guillaud , F. Pietu , M. Vallin
Gastroenterol. Clin. Biol., 2010, 34 (12), pp.721--725
Journal articles hal-01918717v1

Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.

Philippe A Cassier , Thomas R. Walter , Beatrice Eymard , Philippe Ardisson , Maurice Perol
Cancer / Cancer (Phila), 2009, epub ahead of print. ⟨10.1002/cncr.24384⟩
Journal articles hal-00391942v1

Angiogenesis and tumor progression in neuroendocrine digestive tumors.

Gilles Poncet , Karine Villaume , Thomas Walter , Céline Pourreyron , Aurélie Theillaumas
Journal of Surgical Research, 2009, 154 (1), pp.68-77. ⟨10.1016/j.jss.2008.03.055⟩
Journal articles hal-00475688v1

Surgical management of patients with sporadic Zollinger-Ellison Syndrome: An ACHBT and GTE study

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.195
Conference papers hal-04490290v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.29
Conference papers hal-04489996v1

Characterisation, prognosis, and treatment of patients with locally advanced or metastatic thymic carcinoid tumor: A retrospective study of the French GTE-ENDOCAN RENATEN and RYTHMIC networks

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.73
Conference papers hal-04490299v1

Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study)

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.186
Conference papers hal-04490234v1

Etoposide-based rechallenge and second/third line treatments in patients with metastatic neuroendocrine carcinoma: Results from the multicenter RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Thomas Walter
19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.111
Conference papers hal-04490282v1

LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study

Thomas Walter , A. Lievre , R. Coriat , D. Malka , F. El Hajbi
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, Sep 2022, Paris, France. pp.S1412, ⟨10.1016/j.annonc.2022.08.045⟩
Conference papers hal-04489922v1

Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: A GTE study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.104
Conference papers hal-04492492v1

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumors - An international double-blind, placebo-controlled randomized phase 2. Prodige 31 REMINET. A FFCD study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.139
Conference papers hal-04492188v1

LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

N. Girard , J. Mazieres , J. Otto , H. Lena , C. Lepage
Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩
Conference papers hal-04492251v1

OPERA: Observational study of perception of information and quality of life (QoL) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) starting Lanreotide Autogel (LAN)

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.136
Conference papers hal-04492200v1

Cost of carcinoid syndrome (CS) In France: Analysis of the national health insurance database

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.76
Conference papers hal-04492045v1

Prognosis and the role of Rb expression in metastatic grade 3 neuroendocrine carcinoma (G3NEC), results from the multicenter retrospective RbNEC study

Thomas Walter
18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.107
Conference papers hal-04492213v1

Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H08)
Conference papers hal-04493659v1

The PanNENomics Project: A Call for an International Collaborative Effort Built on the Success of the LungNENomics Project

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(C08)
Conference papers hal-04493635v1

OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel-Baseline Characteristics

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(D23)
Conference papers hal-04493628v1

Impact of Small Cell (SC) versus (vs.) Non-Small Cell (nSC) Morphology on Outcomes of Patients (pts) with Extra-Pulmonary, Poorly Differentiated Neuroendocrine Carcinoma (EP-PD-NEC)

Thomas Walter
Abstracts of the 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Barcelona (ES), Spain. pp.(J25)
Conference papers hal-04492643v1

A systematic review and exploratory network meta-analysis of third-line treatments for metastatic colorectal cancer

Thomas Walter
ISPOR 2020 HEOR: Advancing Evidence to Action, May 2020, Orlando (FL), United States. pp.S30
Conference papers hal-04492668v1

Efficacy of Alkylating Agent Re-challenge after Therapeutic Pause in Metastatic Pancreatic Neuroendocrine Tumors (PanNET)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H11)
Conference papers hal-04493642v1

Patient and Nurse Satisfaction with the New Lanreotide Autogel Pre-Filled Syringe in Neuroendocrine Tumors (NET): A Prospective Study (SONATE)

Thomas Walter
17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.H30
Conference papers hal-04493487v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), France. pp.(H07)
Conference papers hal-04495625v1

Carcinoid heart disease (CHD): the CRUSOE-NETs, a prospective cohort study from the French group of endocrine tumours (GTE)

K. Dekeister Geoffroy , L. Francois , Thomas Walter , O. Hentic Dhome , A. Cachier
44th ESMO Congress (ESMO 2019), Sep 2019, Barcelona (ES), Spain. pp.v196, ⟨10.1093/annonc/mdz245.007⟩
Conference papers hal-04493904v1

Framework synthesis of qualitative and quantitative evidence to explore the differential diagnosis of diarrhea in neuroendocrine tumor patients

Thomas Walter
ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR, May 2019, Nouvelle Orléans (LA), United States. pp.S265
Conference papers hal-04493855v1

Temozolomide (TEM) vs Temozolomide-Capecitabine (CAP) in Advanced Pancreatic NET (pNET): A Multicenter Retrospective Analysis of 138 Patients Using a Propensity Score

Thomas Walter
6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(H08)
Conference papers hal-04495620v1

Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter
12th Annual Multidisciplinary Neuroendocrine Tumor Medical Symposium of the North American Neuroendocrine Tumor Society, Oct 2019, Boston (MA), United States. pp.472
Conference papers hal-04493548v1

Endoscopic Management of 345 Small Rectal Neuroendocrine Tumours: A National Study from the French Group of Endocrine Tumours (GTE)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(G01)
Conference papers hal-04495616v1

Differential Diagnosis (DDx) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(J08)
Conference papers hal-04493888v1

The Effect of Carcinoid Syndrome Diarrhea (CSD) Interventions on Patient Experience Outcomes: A Systematic Literature Review (SLR)

Thomas Walter
16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelone (ES), Spain. pp.(J15)
Conference papers hal-04493864v1

Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter
43rd ESMO Congress (ESMO 2018), Mar 2018, Munich (Allemagne), Germany. pp.viii469
Conference papers hal-04495683v1

Perioperative Chemotherapy in Resectable Neuroendocrine Carcinomas of the Digestive Tract

Thomas Walter
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2018, Barcelona (ES), Spain. pp.(H20)
Conference papers hal-04495718v1

Treatment of Metastatic Pancreatic Neuroendocrine Tumors: Relevance of ENETS 2016 Guidelines

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone (ES), Spain. pp.(J6)
Conference papers hal-04500118v1

Patient-Reported Preferences in Treatments Approved in Neuroendocrine Tumors: A National Survey from the French Group of Endocrine Tumors

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R12)
Conference papers hal-04495920v1

Implication of Neuropilin-2 in the Progression of Small Intestinal Neuroendocrine Tumors: Towards a Promising Therapeutic Target

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(A2)
Conference papers hal-04504139v1

Intraoperative Carcinoid Syndrome during Small-Bowel NET Surgery: Description, Prevalence and Risk Factors

Thomas Walter
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R6)
Conference papers hal-04504145v1

Patient Survey Devoted to Characterizing Experience and Expectations of Patients with Neuroendocrine Tumors (NET)

Thomas Walter
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(D59)
Conference papers hal-04495692v1

REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors

C. Lepage , L. Dahan , J.-L. Legoux , K. Le Malicot , R. Guimbaud
The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.187 (J8)
Conference papers hal-01664217v1

Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancreatic (GEP) tract: A multicentre retrospective study

M. Frizziero , X. Wang , B. Chakrabarty , A. Childs , T.V. Luong
42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.155, ⟨10.1093/annonc/mdx368.038⟩
Conference papers hal-04500086v1

Comparison of performances of three technologies for detection of RAS mutations in cfDNA (NGS strategy, BEAMing assay and ddPCR BioRAD assay)

J. Garcia , J. Forestier , E. Dusserre , C. Rodriguez-Lafrasse , V. Cheynet
42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.197, ⟨10.1093/annonc/mdx393.107⟩
Conference papers hal-04499713v1

FFCD Prodige 31 Reminnet

Côme Lepage , L. Dahan , Jean-Louis Legoux , Karine Le Malicot , Rosine Guimbaud
The 14th Annual ENETS Conference, Mar 2017, Barcelone, Spain. , 2017, ⟨10.13140/RG.2.2.35427.35368⟩
Conference poster hal-01578731v1
Image document

MISE EN PLACE ET EVALUATION D'UNE ACTIVITE DE PHARMACIE CLINIQUE EN HOPITAL DE JOUR ONCOLOGIQUE

Fiona Malagutti , Rémi Faure , Thomas Walter , Julien Forestier , Catherine Lombard-Bohas
Xémes Journées de la Société Française de Pharmacie Oncologique, Oct 2015, Nantes, France
Conference poster hal-01214190v1